Timothy R. Rebbeck
Journal of Clinical Oncology · 2001–2022
A researcher in the Science corpus: 9 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Who trusts Timothy R. Rebbeck overall
Papers from Timothy R. Rebbeck's perspective
Ordered by how strongly the researchers Timothy R. Rebbeck trusts endorse each paper. Same corpus, a different order for every researcher.
- Cancer Incidence in BRCA1 mutation carriers. (Journal of the National Cancer Institute)
- The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
- Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. (Journal of the National Cancer Institute)
- Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. (American Journal of Human Genetics)
- Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. (New England Journal of Medicine)
- Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. (Journal of the National Cancer Institute)
- Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. (Journal of the American Medical Association (JAMA))
- Meta-analysis of BRCA1 and BRCA2 penetrance. (Journal of Clinical Oncology)
- Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. (Journal of the American Medical Association (JAMA))
- Accurate Whole Human Genome Sequencing using Reversible Terminator Chemistry (Nature)
Their papers
- Early detection of cancer (2022) — 929 citations
- Comprehensive Genomic Characterization of Long Non-Coding RNAs across Human Cancers (2015) — 606 citations
- Type I and II endometrial cancers: have they different risk factors? (2013) — 749 citations
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers with Cancer Risk and Mortality (2010) — 1,383 citations
- Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers (2009) — 881 citations
- Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. (2004) — 1,067 citations
- Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. (2002) — 764 citations
- Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. (2002) — 1,495 citations
- Metabolic gene polymorphism frequencies in control populations. (2001) — 921 citations